HAMBURG, Germany – Regenerative medicine startup company Precise Bio Inc. is launching a dedicated ophthalmology business unit to help raise funds and attract partners as it continues to develop bio-printed tissues and organs technology that one day could result in a 3D-printed cornea graft in the human eye.